← All Phrases

“weighted deduction”

Business ExpensesSection 35(2AB)Section 35(2AB)486 judgments

The decision most relied on for weighted deduction is CIT v. Claris Lifesciences Ltd. (326 ITR 251), cited in 196 judgments on BharatTax.

Leading authorities on weighted deduction

CIT v. Claris Lifesciences Ltd.
326 ITR 251 · 2010 · High Court
196
citing judgments

If approval from the Department of Scientific and Industrial Research (DSIR) for an in-house R&D centre is granted during the previous year, the assessee is entitled to claim weighted deduction under section 35(2AB) for the entire expenditure incurred during that year.

CIT v. Microlabs Ltd.
383 ITR 490 · 2016 · High Court
175
citing judgments

If an assessee possesses interest-free funds exceeding investments in tax-free securities, it is presumed that investments are made from these own funds, precluding disallowance of interest expenditure under Section 14A read with Rule 8D(2)(ii). Additionally, weighted deduction under Section 35(2AB) is computed on the gross expenditure incurred, not net expenditure after reducing income earned.

CIT v. Sadan Vikas (India) Ltd.
335 ITR 117 · 2011 · High Court
112
citing judgments

Weighted deduction under Section 35(2AB) is allowable for R&D expenditure incurred even if the approval from the DSIR is granted in a subsequent assessment year, provided the application for approval was made in time. The assessee is entitled to the deduction if the approval is based on verification of details submitted.

PCIT v. Maruti Suzuki India Ltd.
397 ITR 681 · 2017 · High Court
84
citing judgments

For claiming weighted deduction under section 35(2AB), the existence of recognition for a Research and Development (R&D) Centre is relevant, not necessarily the date of approval or recognition.

Cummins India Ltd. v. DCIT
96 Taxmann.com 576 · 2018 · ITAT
67
citing judgments

The weighted deduction for scientific research expenditure under Section 35(2AB) is allowable, clarifying that the requirement for the prescribed authority to approve or quantify the expenditure from year to year became effective only from April 1, 2016, through amendments to Rule 6(7A)(b).

CIT v. Cadila Healthcare Ltd.
31 Taxmann.com 300 · 2013 · High Court
65
citing judgments

Section 35(2AB), an incentive provision, allows weighted deduction for expenditure 'on in-house research or development facility' even if related activities like clinical trials are conducted externally, provided they are for the in-house research. This requires a liberal interpretation of the provision.

Sun Pharmaceutical Industries Ltd. v. Pr.CIT
162 ITD 484 · 2017 · ITAT
47
citing judgments

The approval of an in-house R&D centre through Form 3CM is the primary document for claiming weighted deduction under Section 35(2AB) for scientific research expenditure. The case clarifies the significance of this form and the role of the prescribed authority (DSIR) in the approval process.

Tejas Network Ltd. v. DCIT
60 Taxmann.com 309 · 2015 · High Court
41
citing judgments

The Assessing Officer cannot question the correctness of the certificate issued by the prescribed authority for claiming weighted deduction under section 35(2AB) for scientific research expenditure. The deduction is limited to the amount approved and certified by the competent authority.

Judgments citing weighted deduction

Intas Biopharmaceuticals Ltd., Ahmedabad vs. The Dy.Commissioner of Income Tax, Circle-2(1)(1), Ahmedabad

In the result, appeal preferred by the assessee is allowed in part

ITA 865/AHD/2016[2011-12]Status: DisposedITAT Ahmedabad07 Aug 2024AY 2011-12

Bench: Ms. Suchitra Kamble, Judical Member & Shri Narendra Prasad Sinhaआयकर अपील सं./I.T.A. No. 865/Ahd/2016 (िनधा"रण वष" िनधा"रण वष" / Assessment Year : 2011-12) िनधा"रण वष" िनधा"रण वष" Intas The Dy. Commissioner Of बनाम बनाम/ बनाम बनाम Biopharmaceuticals Ltd. Income Tax Vs. Plot 423/P/A, Sarkhej Circle-2(1)(1), Ahmedabad Bavla Highway, Moraiya, Sanand, Ahmedabad, Gujarat, 382213 "थायी लेखा सं./जीआइआर सं./Pan/Gir No. : Aabci4722M (Appellant) .. (Respondent) Shri Bandish Soparkar & Shri Parin अपीलाथ" ओर से /Appellant By : Shah, Ars. ""यथ" क" ओर से/Respondent By : Dr. Darsi Suman Ratnam, Cit. Dr & Shri Ashish Rajesh Revar, Sr. Dr Date Of Hearing 24/07/2024 Date Of Pronouncement 07/08/2024 O R D E R Per Shri Narendra Prasad Sinha, Am: This Appeal Is Filed By The Assessee Against The Order Of The Commissioner Of Income-Tax (Appeals)-7, Ahmedabad (In Short ‘The Cit(A)’) Dated 20.01.2016 For The Assessment Year 2011-12. Ita No. 865/Ahd/2016 [Intas Biopharmaceuticals Ltd. Vs. Dcit] A.Y. 2011-12 - 2 –

For Appellant: Shah, ARsFor Respondent: Dr. Darsi Suman Ratnam, CIT. DR
Section 143(3)Section 35Section 40

disallowance of Rs.50,34,302/- under Section 35(2AB) of the Income Tax Act, 1961 (in short ‘the Act’). The assessee had claimed weighted deduction of Rs.6,66,06,663/- under Section 35(2AB) of the Act @ 200% of in-house Research and Development (R&D) expenses of Rs.3 ... expenditure of Rs.3,13,99,290/- as approved by the DSIR. According to the AO, the assessee was not eligible for claim the weighted deduction @200% of R&D expenditure of Rs.25,17,151/-, which was not approved by the DSIR. Accordingly, he disallowed a sum of Rs.50

Lumis Biotech Private Limited, Mumbai vs. DCIT Circle 7(1)(1), Mumbai

In the result, appeal filed by the assessee is allowed for statistical purposes

ITA 1033/MUM/2024[2018-2019]Status: DisposedITAT Mumbai01 Aug 2024AY 2018-2019

Bench: Shri Pavan Kumar Gadale & Shri Girish Agrawallumis Biotech Pvt Ltd, Vs. Dcit, Circle -7(1)(1), Room No.130, 1St Floor, 501, Arun Chambers, Ayakar Bhavan, Tardeo, M.K.Road, Mumbai-400034. Mumbai -400020. Pan/Gir No. Aaacl1066G (अपीऱाथी/Appellant) (प्रत्यथी/Respondent) Appellant By Shri Hitesh P. Shah.Ar Respondent By Shri Manoj Kumar Sinha, Sr. Dr सुनवाई की तारीख/Date Of Hearing 31.07.2024 घोषणा की तारीख/Date Of Pronouncement 01.08.2024 Order Per Pavan Kumar Gadale, Jm: “ The Appeal Is Filed By The Assessee Against The Order Of National Faceless Appeal Centre (Nfac) Delhi/Cit(A), Passed U/Sec 143(3) & U/Sec 250 Of The Act. The Assessee Has Raised The Following Grounds Of Appeal: 1. The Hon. Cit(A) Ought To Have Appreciated The Fact That The Appellant Could Not Represent Its Case Due To Circumstances Beyond Its Control. 2 The Hon. Cit(A) Was Not Justified In Disregarding The Fact That The Accountant Had Made Inadvertent Mistake In Claiming Deduction U/S.35(2Aa).

Section 35

mistake in claiming deduction U/S.35(2AA). 2 Lumis Biotech Pvt Ltd, Mumbai 3. The Hon. CIT(A) erred in confirming the disallowance of the weighted deduction of expenditure on research and development of Rs. 1,36,40,254/-. 4 The Hon. CIT(A) erred in confirming the addition Rs.6 ... information supporting the claims made in return of income. The AO on perusal of the financial statements found that the assessee has claimed weighted deduction u/s 35(2AA) of the Act of Rs.1,36,40,254/- and find that the assessee has not filed the relevant documents i.e Form

Ami Life Sciences Pvt. Ltd., Vadodara vs. The ACIT, Circle-1(1)(1), Vadodara

Accordingly, the disallowance made by the AO and confirmed by the Ld.CIT(A) is deleted, and the assessee's claim is allowed in full

ITA 544/AHD/2023[2016-17]Status: DisposedITAT Ahmedabad15 Jul 2024AY 2016-17

Bench: Ms. Suchitra Kamble & Shri Makarand V. Mahadeokar, Accountnat Member आयकर अपील सं /Ita No.544/Ahd/2023 "नधा"रण वष" /Assessment Year : 2016-17 Ami Life Sciences Pvt.Ltd. The Acit बनाम/ 701 To 710 Lilleria 1038 Circle-1(1)(1) Next To Zydex Office Vadodara V/S. Gotri Sevasi Road Vadodara – 390 020 (Gujarat) "थायी लेखा सं./Pan: अपीलाथ"/ (Appellant) ….. "" यथ"/ (Respondent) Assessee By : Shri S.N. Soparkar, Sr.Advocate Revenue By : Shri Sudhakar Verma, Sr.Dr सुनवाई क" तार"ख/Date Of Hearing : 04/07/2024 घोषणा क" तार"ख /Date Of Pronouncement: 15/07/2024 आदेश/O R D E R Per Shri Makarand V. Mahadeokar, Am: This Appeal Is Filed By The Assessee As Against The Order Dated 12/06/2023 Passed By The Ld.Commissioner Of Income-Tax(Appeals) - National Faceless Appeal Centre (Nfac), Delhi [Hereinafter Referred To As “The Ld.Cit(A)” In Short], Arising Out Of The Assessment Order Dated 21/12/2018 Passed By The Assessing Officer (Ao) Under Section 143(3) Of The Income Tax Act, 1961 (Hereinafter Referred To As "The Act") Relevant To The Assessment Year (Ay) 2016-17. Ami Life Sciences Pvt.Ltd. Vs. Acit Asst. Year : 2016-17 2 Facts Of The Case:

For Appellant: Shri S.N. Soparkar, Sr.AdvocateFor Respondent: Shri Sudhakar Verma, Sr.DR
Section 143(2)Section 143(3)Section 36Section 36(1)(ii)

Dalal and Broacha Stock Broking Pvt. Ltd of Mumbai Special Bench (ITA No. 5792/Mum/2009 dated 6-12-2010). 2.4. The assessee also had claimed weighted deduction of Rs.3,63,58,968/- u/s.35(2AB). The AO considered report in form 3CL issued by Department of Scientific and Industrial Research (DSIR ... restricted claim of the assessee to Rs.310.92 Lakhs disallowing Rs.26.33 Lacs. The AO allowed revenue expenditure of Rs. 26.33 Lakhs and disallowed weighted deduction amount of Rs. 26.33 Lakhs. 3. Aggrieved by the order of AO, the assessee filed an appeal before the Ld.CIT(A). 4. During the course